136 related articles for article (PubMed ID: 19861431)
1. Identification and characterization of a novel ABCA3 mutation.
Park SK; Amos L; Rao A; Quasney MW; Matsumura Y; Inagaki N; Dahmer MK
Physiol Genomics; 2010 Jan; 40(2):94-9. PubMed ID: 19861431
[TBL] [Abstract][Full Text] [Related]
2. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency.
Matsumura Y; Ban N; Ueda K; Inagaki N
J Biol Chem; 2006 Nov; 281(45):34503-14. PubMed ID: 16959783
[TBL] [Abstract][Full Text] [Related]
3. Functional Characterization of ATP-Binding Cassette Transporter A3 Mutations from Infants with Respiratory Distress Syndrome.
Wambach JA; Yang P; Wegner DJ; Heins HB; Kaliberova LN; Kaliberov SA; Curiel DT; White FV; Hamvas A; Hackett BP; Cole FS
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):716-721. PubMed ID: 27374344
[TBL] [Abstract][Full Text] [Related]
4. Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells.
Weichert N; Kaltenborn E; Hector A; Woischnik M; Schams A; Holzinger A; Kern S; Griese M
Respir Res; 2011 Jan; 12(1):4. PubMed ID: 21214890
[TBL] [Abstract][Full Text] [Related]
5. Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease.
Matsumura Y; Ban N; Inagaki N
Am J Physiol Lung Cell Mol Physiol; 2008 Oct; 295(4):L698-707. PubMed ID: 18676873
[TBL] [Abstract][Full Text] [Related]
6. Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles.
Nagata K; Yamamoto A; Ban N; Tanaka AR; Matsuo M; Kioka N; Inagaki N; Ueda K
Biochem Biophys Res Commun; 2004 Nov; 324(1):262-8. PubMed ID: 15465012
[TBL] [Abstract][Full Text] [Related]
7. Tools to explore ABCA3 mutations causing interstitial lung disease.
Wittmann T; Schindlbeck U; Höppner S; Kinting S; Frixel S; Kröner C; Liebisch G; Hegermann J; Aslanidis C; Brasch F; Reu S; Lasch P; Zarbock R; Griese M
Pediatr Pulmonol; 2016 Dec; 51(12):1284-1294. PubMed ID: 27177387
[TBL] [Abstract][Full Text] [Related]
8. Disruption of N-linked glycosylation promotes proteasomal degradation of the human ATP-binding cassette transporter ABCA3.
Beers MF; Zhao M; Tomer Y; Russo SJ; Zhang P; Gonzales LW; Guttentag SH; Mulugeta S
Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L970-80. PubMed ID: 24142515
[TBL] [Abstract][Full Text] [Related]
9. Quantification of volume and lipid filling of intracellular vesicles carrying the ABCA3 transporter.
Höppner S; Kinting S; Torrano AA; Schindlbeck U; Bräuchle C; Zarbock R; Wittmann T; Griese M
Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2330-2335. PubMed ID: 28887056
[TBL] [Abstract][Full Text] [Related]
10. Neonatal respiratory failure due to novel compound heterozygous mutations in the ABCA3 lipid transporter.
Oltvai ZN; Smith EA; Wiens K; Nogee LM; Luquette M; Nelson AC; Wikenheiser-Brokamp KA
Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32532878
[TBL] [Abstract][Full Text] [Related]
11. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation.
Bullard JE; Nogee LM
Pediatr Res; 2007 Aug; 62(2):176-9. PubMed ID: 17597647
[TBL] [Abstract][Full Text] [Related]
12. Functional rescue of misfolding ABCA3 mutations by small molecular correctors.
Kinting S; Höppner S; Schindlbeck U; Forstner ME; Harfst J; Wittmann T; Griese M
Hum Mol Genet; 2018 Mar; 27(6):943-953. PubMed ID: 29325094
[TBL] [Abstract][Full Text] [Related]
13. ABCA3 gene mutations in newborns with fatal surfactant deficiency.
Shulenin S; Nogee LM; Annilo T; Wert SE; Whitsett JA; Dean M
N Engl J Med; 2004 Mar; 350(13):1296-303. PubMed ID: 15044640
[TBL] [Abstract][Full Text] [Related]
14. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome.
Cheong N; Madesh M; Gonzales LW; Zhao M; Yu K; Ballard PL; Shuman H
J Biol Chem; 2006 Apr; 281(14):9791-800. PubMed ID: 16415354
[TBL] [Abstract][Full Text] [Related]
15. ABCA3, a key player in neonatal respiratory transition and genetic disorders of the surfactant system.
Peca D; Cutrera R; Masotti A; Boldrini R; Danhaive O
Biochem Soc Trans; 2015 Oct; 43(5):913-9. PubMed ID: 26517903
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of heterozygous ABCA3 mutations in children].
Xu X; Liu E; Luo Z; Luo J; Fu Z
Zhonghua Er Ke Za Zhi; 2014 Apr; 52(4):244-7. PubMed ID: 24915907
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus potentiates ABCA3 mutation-induced loss of lung epithelial cell differentiation.
Kaltenborn E; Kern S; Frixel S; Fragnet L; Conzelmann KK; Zarbock R; Griese M
Hum Mol Genet; 2012 Jun; 21(12):2793-806. PubMed ID: 22434821
[TBL] [Abstract][Full Text] [Related]
18. Homooligomerization of ABCA3 and its functional significance.
Frixel S; Lotz-Havla AS; Kern S; Kaltenborn E; Wittmann T; Gersting SW; Muntau AC; Zarbock R; Griese M
Int J Mol Med; 2016 Aug; 38(2):558-66. PubMed ID: 27352740
[TBL] [Abstract][Full Text] [Related]
19. Biologic characterization of ABCA3 variants in lung tissue from infants and children with ABCA3 deficiency.
Xu KK; Wegner DJ; Geurts LC; Heins HB; Yang P; Hamvas A; Eghtesady P; Sweet SC; Sessions Cole F; Wambach JA
Pediatr Pulmonol; 2022 May; 57(5):1325-1330. PubMed ID: 35170262
[TBL] [Abstract][Full Text] [Related]
20. An intronic ABCA3 mutation that is responsible for respiratory disease.
Agrawal A; Hamvas A; Cole FS; Wambach JA; Wegner D; Coghill C; Harrison K; Nogee LM
Pediatr Res; 2012 Jun; 71(6):633-7. PubMed ID: 22337229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]